Portfolio company
Visby Medical
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops portable, single-use molecular diagnostic devices for clinicians and consumers to detect infectious diseases, including respiratory and sexual health conditions.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
Testmate Health
This company develops rapid urine-based diagnostic kits for individuals to test for sexually transmitted infections at home without requiring laboratory processing.
Videm
Videm develops a handheld diagnostic device for rapid molecular and protein detection of infectious diseases in care settings and at home.
Binx Health
This company develops molecular point-of-care diagnostic platforms for rapid chlamydia and gonorrhea testing, serving clinics, student health centres and urgent care providers.
VedaBio
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
Inflammatix
This company develops point-of-care molecular diagnostic tests for healthcare providers to identify acute infections and sepsis by reading the body's immune response.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
